Please login to the form below

oncolytic viruses

This page shows the latest oncolytic viruses news and features for those working in and with pharma, biotech and healthcare.

Catalent preps for complex therapy boom with $1.2bn Paragon buy

Paragon, which is backed by private-equity firms Camden Partners and NewSpring Capital, helps its clients develop and produce gene therapies, next-generation vaccines, and other complex biopharmaceuticals such as oncolytic ... viruses and CAR-T cell

Latest news

Boehringer bolts on another immuno-oncology company

The company currently has clinical-phase projects ranging across checkpoint inhibitors, oncolytic viruses, cancer vaccines and T-cell engagers, with around half of its early-to-mid-stage pipeline emerging from ... 2006. Other oncolytic virus candidates
Vyriad inks immunotherapy alliance with Merck/Pfizer

Oncolytic viruses are engineered to selectively replicate within and destroy cancer cells while simultaneously augmenting anti-tumour immunity, and are generally injected directly into tumour sites. ... There’s a lot of activity going on in R&D however,
J&J pays $140m upfront for cancer-busting virus firm BeneVir

that the promise of oncolytic viruses will come to fruition when they are used in combination with other cancer immunotherapies. ... The biotech’s website indicates that its oncolytic viruses lend themselves to co-administration with immune checkpoint
Sanofi’s latecomer PD-1 gets date for FDA verdict

and oncolytic viruses.
Boehringer buys into oncolytic viruses via €210m ViraTherapeutics deal

The deal - valued at up to 210m ($236m) - gives Boehringer joint development rights to vesicular stomatitis virus glycoprotein (VSV-GP), a platform technology for the creation of oncolytic viruses which treat ... Boehringer says VSV-GP has a shorter

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Latest Intelligence

Cancer immunotherapy: What's on the horizon?

cell-based therapies and oncolytic viruses that attack malignant cells directly, and cancer vaccines that try to kickstart an intrinsic immune reaction to the tumour. ... Oncolytic viruses. An oncolytic virus is a virus that preferentially infects and
Gene therapy

From a payload perspective, these include new technologies such as siRNA, Sleeping Beauty transposases, CRISPR-Cas9 gene editing, ARCUS gene editing, nucleic acid vaccines, oncolytic viruses and chemically modified mRNA. ... In contrast, viruses still
Deal Watch December 2016

995+. PsiOxus Therapeutics (UK). BMS (US). Licence. NG-348: preclinical “armed” oncolytic virus targeting tumour cells. ... technology in the development of immunomodulatory oncolytic viruses.
The Maverick: giving medicines away free

His fundamental idea is to create synthetic viruses that can invade cancer cells, destroy them, and then multiply into more viruses to kill the remaining cancerous cells. ... This forms part of a new research area known as oncolytic virology that uses

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

Turnstone Biologics bolsters leadership team

Oncolytic viruses and cancer vaccines have the potential to benefits a wide range of patients living with cancer, and the company’s proprietary viral platform technology is at the forefront of ... we advance clinical development of our next-generation

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Products as portfolios: positioning immuno-oncology products

In addition, developments in oncolytic viruses mean the options for patients with certain solid tumours are ever-expanding.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Director – Healthcare PR: Salary TBC

PR Associate Director – Consumer Health & Beauty: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer: Competitive salary and benefits

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Senior Medical Writer: Salary TBC

Account Director, Medical Education: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Editor – Medical Education Agency – Bucks: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...